These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5550233)

  • 1. [Comparative clinical and morphological studies of 2 oral contraceptives containing DL-norgestrel or D-norgestre].
    Brosens I; Van Assche A; Wijnants P
    Geburtshilfe Frauenheilkd; 1971 Mar; 31(3):251-7. PubMed ID: 5550233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypophyseal reaction state during oral contraceptiva (author's transl)].
    Gitsch E; Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1981 Oct; 93(19):599-601. PubMed ID: 6798764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of two oral contraceptives containing DL norgestrel and D norgestrel.
    Koetsawang S; Rimdusit S; Srivanaboon S; Bhiraleus P; Rachawat D
    J Med Assoc Thai; 1973 May; 56(5):314-8. PubMed ID: 4783789
    [No Abstract]   [Full Text] [Related]  

  • 7. A clinico-pathological study of Neogynon as a new oral contraceptive steroid.
    El-zenieny AH; El-kabarity H; Hafiz MA; Fikry MF
    Ain Shams Med J; 1976 Mar; 27(2):213-6. PubMed ID: 12261440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A low-dose combination oral contraceptive. Experience with 1,700 women treated for 22,489 cycles.
    Woutersz TB
    J Reprod Med; 1981 Dec; 26(12):615-20. PubMed ID: 7033528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptives: selection of the proper pill.
    Dickey RP; Dorr CH
    Obstet Gynecol; 1969 Feb; 33(2):273-87. PubMed ID: 5775187
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hair-growth disorders in relation to pregnancy and hormonal contraception].
    Zaun H
    Z Geburtshilfe Perinatol; 1973 Apr; 177(2):67-73. PubMed ID: 4578114
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences in the long term use of Norgestrel plus Ethinylestradiol (Eugynon)].
    Süssmann F
    Med Welt; 1968 Mar; 10():659-61. PubMed ID: 5706215
    [No Abstract]   [Full Text] [Related]  

  • 13. Norgestrel and ethynyl estradiol: a new low-dosage oral agent for fertility control.
    Rice-Wray E; Avila C; Gutiérrez J
    Obstet Gynecol; 1968 Mar; 31(3):368-74. PubMed ID: 5639191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observations with a combined oral contraceptive (Rigevidon) containing minimum oestrogen dose.
    Karsay K
    Ther Hung; 1980; 28(1):17-20. PubMed ID: 7281074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triphasil--a new triphasic oral contraceptive.
    Med Lett Drugs Ther; 1985 May; 27(688):48. PubMed ID: 4000059
    [No Abstract]   [Full Text] [Related]  

  • 16. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial of an oral contraceptive containing desogestrel and ethinyl estradiol.
    Weijers MJ
    Clin Ther; 1982; 4(5):359-66. PubMed ID: 6461412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol.
    Goldzieher JW
    J Reprod Med; 1983 Jan; 28(1 Suppl):53-6. PubMed ID: 6403700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America.
    Moggia AV
    J Reprod Med; 1983 Jan; 28(1 Suppl):77-80. PubMed ID: 6403704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and therapeutic study of a combination of ethinyl nortestosterone acetate and ethinyl estradiol].
    Magnier P
    Gynecol Prat; 1968; 19(1):21-43. PubMed ID: 5748205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.